182 related articles for article (PubMed ID: 21206915)
21. Primary dengue virus infections induce differential cytokine production in Mexican patients.
Cruz Hernández SI; Puerta-Guardo HN; Flores Aguilar H; González Mateos S; López Martinez I; Ortiz-Navarrete V; Ludert JE; Angel RM
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):161-7. PubMed ID: 27008374
[TBL] [Abstract][Full Text] [Related]
22. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of aminotransferase abnormality in dengue patients: A meta analysis.
Wang XJ; Wei HX; Jiang SC; He C; Xu XJ; Peng HJ
Acta Trop; 2016 Apr; 156():130-6. PubMed ID: 26739659
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.
Liao B; Tang Y; Hu F; Zhou W; Yao X; Hong W; Wang J; Zhang X; Tang X; Zhang F
Emerg Microbes Infect; 2015 Apr; 4(4):e24. PubMed ID: 26421267
[TBL] [Abstract][Full Text] [Related]
25. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
[TBL] [Abstract][Full Text] [Related]
26. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.
Libraty DH; Endy TP; Houng HS; Green S; Kalayanarooj S; Suntayakorn S; Chansiriwongs W; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
J Infect Dis; 2002 May; 185(9):1213-21. PubMed ID: 12001037
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of hemorrhage in dengue without circulatory collapse.
Krishnamurti C; Kalayanarooj S; Cutting MA; Peat RA; Rothwell SW; Reid TJ; Green S; Nisalak A; Endy TP; Vaughn DW; Nimmannitya S; Innis BL
Am J Trop Med Hyg; 2001 Dec; 65(6):840-7. PubMed ID: 11791984
[TBL] [Abstract][Full Text] [Related]
28. Serum IL-10 as a marker of severe dengue infection.
Malavige GN; Gomes L; Alles L; Chang T; Salimi M; Fernando S; Nanayakkara KD; Jayaratne S; Ogg GS
BMC Infect Dis; 2013 Jul; 13():341. PubMed ID: 23883139
[TBL] [Abstract][Full Text] [Related]
29. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large.
Kurane I; Takasaki T
Rev Med Virol; 2001; 11(5):301-11. PubMed ID: 11590668
[TBL] [Abstract][Full Text] [Related]
30. Dengue in the early febrile phase: viremia and antibody responses.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 1997 Aug; 176(2):322-30. PubMed ID: 9237696
[TBL] [Abstract][Full Text] [Related]
31. Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017.
Ngwe Tun MM; Nguyen TTT; Ando T; Dumre SP; Soe AM; Buerano CC; Nguyen MT; Le NTN; Pham VQ; Nguyen TH; Le TQM; Morita K; Hasebe F
Am J Trop Med Hyg; 2020 Jun; 102(6):1217-1225. PubMed ID: 32189614
[TBL] [Abstract][Full Text] [Related]
32. Elevation in liver enzymes is associated with increased IL-2 and predicts severe outcomes in clinically apparent dengue virus infection.
Senaratne T; Carr J; Noordeen F
Cytokine; 2016 Jul; 83():182-188. PubMed ID: 27155816
[TBL] [Abstract][Full Text] [Related]
33. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
34. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis.
Wang WK; Chao DY; Kao CL; Wu HC; Liu YC; Li CM; Lin SC; Ho ST; Huang JH; King CC
Virology; 2003 Jan; 305(2):330-8. PubMed ID: 12573578
[TBL] [Abstract][Full Text] [Related]
35. Dengue fever. Clinical features of 567 consecutive patients admitted to a tertiary care center in Saudi Arabia.
Badreddine S; Al-Dhaheri F; Al-Dabbagh A; Al-Amoudi A; Al-Ammari M; Elatassi N; Abbas H; Magliah R; Malibari A; Almoallim H
Saudi Med J; 2017 Oct; 38(10):1025-1033. PubMed ID: 28917067
[TBL] [Abstract][Full Text] [Related]
36. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever.
Cam BV; Fonsmark L; Hue NB; Phuong NT; Poulsen A; Heegaard ED
Am J Trop Med Hyg; 2001 Dec; 65(6):848-51. PubMed ID: 11791985
[TBL] [Abstract][Full Text] [Related]
37. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
38. Cytokine Signature Associated with Disease Severity in Dengue.
Patro ARK; Mohanty S; Prusty BK; Singh DK; Gaikwad S; Saswat T; Chattopadhyay S; Das BK; Tripathy R; Ravindran B
Viruses; 2019 Jan; 11(1):. PubMed ID: 30626045
[TBL] [Abstract][Full Text] [Related]
39. Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level.
Pal T; Dutta SK; Mandal S; Saha B; Tripathi A
J Clin Virol; 2014 Nov; 61(3):365-70. PubMed ID: 25288310
[TBL] [Abstract][Full Text] [Related]
40. IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever.
Flores-Mendoza LK; Estrada-Jiménez T; Sedeño-Monge V; Moreno M; Manjarrez MDC; González-Ochoa G; Millán-Pérez Peña L; Reyes-Leyva J
Mediators Inflamm; 2017; 2017():5197592. PubMed ID: 28827898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
